Chemical priming potentiates mesothelin-targeting chimeric antigen receptor-engineered NK-92 antitumor activity by improving tumor trafficking and cytotoxic killing dynamics - Quiz - MDSpire

Chemical priming potentiates mesothelin-targeting chimeric antigen receptor-engineered NK-92 antitumor activity by improving tumor trafficking and cytotoxic killing dynamics

  • By

  • Ki Seo Ryu

  • Hail Park

  • Eunchong Maeng

  • Jun-Yeon Lim

  • Duck Cho

  • Seung Hee Choi

  • Kyung-Soon Park

  • June 1, 2026

  • 0 min

Share

Original Source(s)

Chemical priming potentiates mesothelin-targeting chimeric antigen receptor-engineered NK-92 antitumor activity by improving tumor trafficking and cytotoxic killing dynamics

  • by Ki Seo Ryu, Hail Park, Eunchong Maeng, Jun-Yeon Lim, Duck Cho, Seung Hee Choi, Kyung-Soon Park

  • June 1, 2026

Related Content

MAGE-A4/MAGE-A8-targeted TCR-based bispecific T cell engager in recurrent and/or refractory solid tumors: a phase 1 trial

Engineered virus-hunter vaccine overcomes HBV immune tolerance

From monoclonals to bispecific T cell engagers: the evolving antibody-based therapy landscape in acute myeloid leukemia